200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 141136-83-6

141136-83-6

141136-83-6 | L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine

CAS No: 141136-83-6 Catalog No: AG003AP5 MDL No:

Product Description

Catalog Number:
AG003AP5
Chemical Name:
L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine
CAS Number:
141136-83-6
Molecular Formula:
C34H56N10O9
Molecular Weight:
748.8700
IUPAC Name:
(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid
InChI:
InChI=1S/C34H56N10O9/c1-18(2)13-23(30(49)40-22(11-8-12-39-34(37)38)29(48)44-26(33(52)53)16-27(36)46)42-31(50)24(14-19(3)4)43-32(51)25(41-28(47)21(35)17-45)15-20-9-6-5-7-10-20/h5-7,9-10,18-19,21-26,45H,8,11-17,35H2,1-4H3,(H2,36,46)(H,40,49)(H,41,47)(H,42,50)(H,43,51)(H,44,48)(H,52,53)(H4,37,38,39)/t21-,22-,23-,24-,25-,26-/m0/s1
InChI Key:
HAGOWCONESKMDW-FRSCJGFNSA-N
SMILES:
OC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(=O)N)CCCNC(=N)N)CC(C)C)CC(C)C)Cc1ccccc1)N

Properties

Complexity:
1270  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
6  
Defined Bond Stereocenter Count:
0
Exact Mass:
748.423g/mol
Formal Charge:
0
Heavy Atom Count:
53  
Hydrogen Bond Acceptor Count:
11  
Hydrogen Bond Donor Count:
11  
Isotope Atom Count:
0
Molecular Weight:
748.883g/mol
Monoisotopic Mass:
748.423g/mol
Rotatable Bond Count:
24  
Topological Polar Surface Area:
337A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.8  

Literature

Title Journal
TCDD and omeprazole prime platelets through the aryl hydrocarbon receptor (AhR) non-genomic pathway. Toxicology letters 20150519
Antioxidative properties of hydrogen sulfide may involve in its antiadhesive action on blood platelets. Clinical biochemistry 20121201
The activation of protease-activated receptor 1 mediates proliferation and invasion of nasopharyngeal carcinoma cells. Oncology reports 20120701
Thrombin stimulates integrin β1-dependent adhesion of human pancreatic cancer cells to vitronectin through protease-activated receptor (PAR)-1. Hepato-gastroenterology 20120101
PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets. Journal of thrombosis and haemostasis : JTH 20110801
Platelet function following trauma. A multiple electrode aggregometry study. Thrombosis and haemostasis 20110801
Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase. The Journal of biological chemistry 20110708
The effect of intravenous high-dose methylprednisolone on platelet reactivity assessed with multiple electrode aggregometry. Thrombosis and haemostasis 20110601
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thrombosis and haemostasis 20110401
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation. Journal of thrombosis and haemostasis : JTH 20110301
Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 20110201
Measurement of platelet function in dogs using a novel impedance aggregometer. Veterinary journal (London, England : 1997) 20100801
Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nature biotechnology 20100701
A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Anesthesia and analgesia 20100301
Mild and moderate hypothermia increases platelet aggregation induced by various agonists: a whole blood in vitro study. Platelets 20100101
Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel? Platelets 20100101
Valproic acid and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01. Platelets 20100101
Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets. Platelets 20090901
Proteinase-activated receptor-1 activation presynaptically enhances spontaneous glutamatergic excitatory transmission in adult rat substantia gelatinosa neurons. Journal of neurophysiology 20090701
Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets. The Journal of biological chemistry 20090501
Impaired activation of platelets lacking protein kinase C-theta isoform. Blood 20090312
Histone H3 as a novel substrate for MAP kinase phosphatase-1. American journal of physiology. Cell physiology 20090201
The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 20090201
Whole-blood aggregometry: are there any limits with regard to platelet counts? Acta anaesthesiologica Scandinavica 20090101
Endothelium-derived hyperpolarizing factor mediated relaxations in pig coronary arteries do not involve Gi/o proteins. Acta pharmacologica Sinica 20081201
Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment. Integrative cancer therapies 20081201
Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thrombosis and haemostasis 20081201
Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin. The Journal of biological chemistry 20081003
Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. Journal of thrombosis and haemostasis : JTH 20080801
The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine. Platelets 20080801
The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine. The Journal of biological chemistry 20080704
Development of proteomic signatures of platelet activation using surface-enhanced laser desorption/ionization technology in a clinical setting. American journal of clinical pathology 20080601
Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans. Anesthesia and analgesia 20080601
Multiple electrode aggregometry and P2Y(12) antagonists. Thrombosis and haemostasis 20080601
Fluoxetine (Prozac) augments platelet activation mediated through protease-activated receptors. Journal of thrombosis and haemostasis : JTH 20080401
Elevated platelet reactivity in stable angina pectoris without significant coronary flow obstruction. Journal of cardiovascular medicine (Hagerstown, Md.) 20080201
Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. The Journal of neuroscience : the official journal of the Society for Neuroscience 20080116
VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration. American journal of physiology. Cell physiology 20080101
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thrombosis and haemostasis 20080101
Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. The Journal of pharmacology and experimental therapeutics 20070801
Osteosarcoma cell-calcium signaling through tissue factor-factor VIIa complex and factor Xa. FEBS letters 20070612
Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Arteriosclerosis, thrombosis, and vascular biology 20070601
Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood. Thrombosis and haemostasis 20070601
Adenosine opposes thrombin-induced inhibition of intercellular calcium wave in corneal endothelial cells. Investigative ophthalmology & visual science 20070401
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Thrombosis and haemostasis 20070301
Ex vivo microvesicle formation after prolonged ischemia in renal transplantation. Thrombosis research 20070101
[Activation of cardiac contractivity of the edible snail H. pomatia under effect of thrombin. Study of role of cAMP]. Zhurnal evoliutsionnoi biokhimii i fiziologii 20070101
[Role of adenosine diphosphate in the course of thrombin signal transmission]. Zhonghua yi xue za zhi 20061212
PAR-1-dependent pp60src activation is dependent on protein kinase C and increased [Ca2+]: evidence that pp60src does not regulate PAR-1-dependent Ca2+ entry in human platelets. Journal of thrombosis and haemostasis : JTH 20061201
Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 20061201
Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thrombosis and haemostasis 20061201
Factor VIII is a positive regulator of platelet function. Platelets 20061101
Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans. Circulation 20061010
Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. European journal of pharmacology 20060928
Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets? Platelets 20060901
Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors. Molecular pharmacology 20060601
ThromboFix platelet stabilizer: advances in clinical platelet analyses by flow cytometry? Platelets 20060601
Actin polymerisation regulates thrombin-evoked Ca(2+) signalling after activation of PAR-4 but not PAR-1 in human platelets. Platelets 20060501
The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts). Histochemistry and cell biology 20060401
Fibrin sealant promotes migration and proliferation of human articular chondrocytes: possible involvement of thrombin and protease-activated receptors. International journal of molecular medicine 20060401
Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Annals of hematology 20060201
The influence of bromelain on platelet count and platelet activity in vitro. Platelets 20060201
Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma. Thrombosis research 20060101
[Biodegradable microparticles with immobilized peptide for wound healing]. Biomeditsinskaia khimiia 20060101
The actin cytoskeleton differentially regulates platelet alpha-granule and dense-granule secretion. Blood 20050515
Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction. Arteriosclerosis, thrombosis, and vascular biology 20050201
Inverse relationships between coronary blood flow obstruction and platelet reactivity in stable angina pectoris. Platelets 20050101
alpha-thrombin rapidly induces tyrosine phosphorylation of a novel, 74-78-kDa stress response protein(s) in lung fibroblast cells. The Journal of biological chemistry 20041119
Signaling mechanisms involved in protease-activated receptor-1-mediated interleukin-6 production by human gingival fibroblasts. The Journal of pharmacology and experimental therapeutics 20041101
Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. Journal of leukocyte biology 20041101
Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1. The Biochemical journal 20040915
Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses. Blood 20040901
Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arteriosclerosis, thrombosis, and vascular biology 20040901
Effects of inhaled thrombin receptor agonists in mice. British journal of pharmacology 20040901
The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates. Transfusion 20040901
The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesthesia and analgesia 20040901
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 20040824
Akt activation in platelets depends on Gi signaling pathways. The Journal of biological chemistry 20040206
PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology (Baltimore, Md.) 20040201
Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets. The Journal of biological chemistry 20040123
The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism. Leukemia & lymphoma 20030901
High-affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus. Bioorganic & medicinal chemistry letters 20030707
Thrombin downregulates muscle acetylcholine receptors via an IP3 signaling pathway by activating its G-protein-coupled protease-activated receptor-1. Journal of cellular physiology 20030701
Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. The Journal of physiology 20030615
Thrombin-induced Ca2+ mobilization in human gingival fibroblasts is mediated by protease-activated receptor-1 (PAR-1). Life sciences 20030606
Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation 20030603
Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle. British journal of pharmacology 20030601
Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry. Thrombosis research 20030315
Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 20030201
Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood--different effects of collagen, TRAP and calcium ionophore A23187. Thrombosis and haemostasis 20030101
Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. The Biochemical journal 20021201
Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circulation research 20020920
Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism. Thrombosis research 20020915
Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Thrombosis and haemostasis 20020601
Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 20020515
Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. The Biochemical journal 20020501
Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome. Thrombosis and haemostasis 20020401
Identification of functional VEGF receptors on human platelets. FEBS letters 20020213
Participation of protease-activated receptor-1 in thrombin-induced microglial activation. Journal of neurochemistry 20020201
Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood. Anesthesiology 20020101
[Polymer coatings with immobilized thrombin and peptides: preparation and use for wound healing]. Voprosy meditsinskoi khimii 20020101
Thrombin and PAR-1 activating peptide increase iNOS expression in cytokine-stimulated C6 glioma cells. Journal of neurochemistry 20011101
Platelet aggregation is not initiated by platelet shape change. Laboratory investigation; a journal of technical methods and pathology 20011101
[The role of PAR family receptors in activation of mast cells in the norm and in acute inflammation in rats]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20011101
Aprotinin: is it prothrombotic? Perfusion 20010901
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT. Circulation 20010724
Tritiated photoactivatable analogs of the native human thrombin receptor (PAR-1) agonist peptide, SFLLRN-NH2. The journal of peptide research : official journal of the American Peptide Society 20010601
Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20010401
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk. Journal of thrombosis and thrombolysis 20010401
Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats. Thrombosis research 20010315
Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 20010301
Thrombin-stimulated growth, clustering, and collagen lattice contraction of human gingival fibroblasts is associated with its protease activity. Journal of periodontology 20010301
The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma. Journal of neural transmission (Vienna, Austria : 1996) 20010101
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 20001215
In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. European journal of pharmacology 19991119
Transcellular signaling and pharmacological modulation of thrombin-induced production of plasminogen activator inhibitor-1 in vascular smooth muscle cells. Seminars in thrombosis and hemostasis 19980101
Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. Journal of cardiovascular pharmacology 19971101
Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells. The Biochemical journal 19960315

© 2019 Angene International Limited. All rights Reserved.